Ondine Biomedical Inc.
LSE: OBI.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Carolyn Cross
- Employees
- 18
- Headquarters
- Vancouver, Canada
- IPO year
- 2021
- Market cap
- £60.0M
- Website
- https://www.ondinebio.com
Loading OBI…
Loading profile data…Frequently asked questions about OBI
What does Ondine Biomedical Inc. (OBI.L) do?
Ondine Biomedical Inc., a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens. The company's lead product is Steriwa...
Where does OBI.L trade?
Ondine Biomedical Inc. (OBI.L) trades on the London Stock Exchange.
What sector is OBI.L in?
Ondine Biomedical Inc. (OBI.L) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Ondine Biomedical Inc.?
Carolyn Cross is the chief executive officer of Ondine Biomedical Inc. (OBI.L).
Where is Ondine Biomedical Inc. headquartered?
Ondine Biomedical Inc. is headquartered in Canada.
Does OBI.L pay a dividend?
Ondine Biomedical Inc. (OBI.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did OBI.L go public?
Ondine Biomedical Inc. (OBI.L) completed its initial public offering in 2021.